The Clinical Characteristics, Treatment and Prognosis of Tuberculosis-Associated Chronic Obstructive Pulmonary Disease: A Protocol for a Multicenter Prospective Cohort Study in China
Zhihan Jiang,Yingying Dai,Jing Chang,Pingchao Xiang,Zhenyu Liang,Yan Yin,Yongchun Shen,Ruiying Wang,Bianba Qiongda,Hongling Chu,Nan Li,Xiaoyan Gai,Ying Liang,Yongchang Sun
DOI: https://doi.org/10.2147/copd.s475451
2024-09-26
International Journal of COPD
Abstract:Zhihan Jiang, 1, &ast Yingying Dai, 2, &ast Jing Chang, 2 Pingchao Xiang, 3 Zhenyu Liang, 4 Yan Yin, 5 Yongchun Shen, 6 Ruiying Wang, 7 Bianba Qiongda, 8 Hongling Chu, 9 Nan Li, 9 Xiaoyan Gai, 1, 10 Ying Liang, 1, 10 Yongchang Sun 1, 10 1 Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, People's Republic of China; 2 School of Basic Medical Sciences, Peking University, Beijing, People's Republic of China; 3 Department of Respiratory and Critical Care Medicine, Peking University Shougang Hospital, Beijing, People's Republic of China; 4 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, GuangZhou, People's Republic of China; 5 Department of Respiratory and Critical Care Medicine, The First Hospital of China Medical University, Shenyang, People's Republic of China; 6 Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China; 7 Department of Respiratory and Critical Care Medicine, Shanxi Bethune Hospital, Taiyuan, People's Republic of China; 8 Department of Respiratory and Critical Care Medicine, Tibet Autonomous Region People's Hospital, Lhasa, People's Republic of China; 9 Clinical Epidemiology Research Center, Peking University Third Hospital, Beijing, People's Republic of China; 10 Research Center for Chronic Airway Diseases, Peking University Health Science Center, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ying Liang; Yongchang Sun, Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, North Garden Road 49, Haidian District, Beijing, People's Republic of China, Tel +86 13810964766 ; +86 13910979132, Fax +86 108 226 6989, Email ; Background: Tuberculosis and chronic obstructive pulmonary disease (COPD) are significant public health challenges, with pulmonary tuberculosis recognized as a pivotal risk factor for the development of COPD. Tuberculosis-associated COPD is increasingly recognized as a distinct phenotype of COPD that potentially exhibits unique clinical features. A thorough understanding of the precise definition, clinical manifestations, prognosis, and most effective pharmacological strategies for tuberculosis-associated COPD warrants further investigation. Methods: This prospective, observational cohort study aims to enroll over 135 patients with tuberculosis-associated COPD and 405 patients with non-tuberculosis-associated COPD, across seven tertiary hospitals in mainland China. The diagnosis of tuberculosis-associated COPD will be established based on the following criteria: (1) history of pulmonary tuberculosis with standard antituberculosis treatment; (2) suspected pulmonary tuberculosis with radiological evidence indicative of tuberculosis sequelae; (3) no definitive history of pulmonary tuberculosis but with positive interferon-gamma release assay results and radiological signs suggestive of tuberculosis. At baseline, demographic information, medical history, respiratory questionnaires, complete blood count, interferon-gamma release assays, medications, spirometry, and chest computed tomography (CT) scans will be recorded. Participants will be followed for one year, with evaluations at six-month intervals to track the longitudinal changes in symptoms, treatment, lung function, and frequencies of COPD exacerbations and hospitalizations. At the final outpatient visit, additional assessments will include chest CT scans and total medical costs incurred. Discussion: The findings of this study are expected to delineate the specific characteristics of tuberculosis-associated COPD and may propose potential treatment options for this particular phenotype, potentially leading to improved clinical management and patient outcomes. Keywords: chronic obstructive pulmonary disease, COPD, pulmonary tuberculosis, tuberculosis-associated COPD, protocol Chronic obstructive pulmonary disease (COPD), characterized by chronic respiratory symptoms and persistent airflow limitation, 1 is the third leading cause of death worldwide and results in approximately 3.3 million deaths annually, which imposes a substantial health and economic burden worldwide, especially in developing countries. 2,3 Pulmonary tuberculosis, another global health problem, 4 has been confirmed as an important risk factor f -Abstract Truncated-
respiratory system